Unit Converter
Creatine Kinase (CK)

SI UNITS (recommended)

CONVENTIONAL UNITS

(Total CK – Marker of Muscle Injury, Myocardial Damage & Rhabdomyolysis)

Synonyms

  • CK
  • Creatine kinase
  • CPK (older term)
  • Total CK
  • Creatine phosphokinase
  • ATP:creatine phosphotransferase

Units of Measurement

  • nkat/L
  • µkat/L
  • nmol/(s·L)
  • µmol/(s·L)
  • U/L
  • IU/L
  • µmol/(min·L)
  • µmol/(h·L)
  • µmol/(h·mL)

Description

Creatine kinase (CK) is a cytosolic enzyme involved in energy metabolism of muscle cells. It catalyzes:

Creatine phosphate+ADP↔Creatine+ATP\text{Creatine phosphate} + \text{ADP} \leftrightarrow \text{Creatine} + \text{ATP}Creatine phosphate+ADP↔Creatine+ATP

CK is abundant in:

  • Skeletal muscle (CK-MM)
  • Cardiac muscle (CK-MB)
  • Brain (CK-BB)

Total CK is a sensitive marker of muscle injury, but not specific to any one tissue.

Physiological Role

  • Regenerates ATP during muscle contraction
  • Maintains cellular energy stores
  • Highly expressed in metabolically active tissues

Clinical Significance

High CK (Hyper-CK-emia)

1. Skeletal Muscle Injury (Most Common)

  • Rhabdomyolysis (CK often >5000–10,000 U/L)
  • Trauma / crush injury
  • Strenuous exercise
  • Seizures
  • Myositis (viral, autoimmune)
  • Muscular dystrophies (DMD, BMD)
  • Drug-induced: statins, fibrates, antipsychotics

2. Myocardial Infarction (Historically)

CK-MB preferred over total CK - troponins now gold standard.

3. Hypothyroidism

Can elevate CK significantly.

4. Renal Failure

CK rises due to decreased clearance and muscle injury.

5. Infections

Myositis (influenza, HIV, COVID) → high CK.

Low CK

Rare and usually not clinically significant.
Seen in:

  • Aging
  • Low muscle mass
  • Chronic steroid use

Low CK values generally not interpreted diagnostically.

Reference Intervals

(Tietz 8E + IFCC + Mayo + ARUP)

Ranges vary by age, sex, race, and muscle mass.

Adult Reference Ranges (Typical)

  • Men: 40 – 200 U/L
  • Women: 30 – 170 U/L

Children

Higher levels due to increased muscle turnover.

Critical Values

  • CK > 5000–10,000 U/L → risk of AKI (rhabdomyolysis)
  • CK > 20,000–50,000 U/L → severe rhabdomyolysis

Units Description & Conversion Factors

CK measurements reflect ENZYME ACTIVITY, not mass.**

1 katal (kat) = 1 mol/s of enzymatic activity

Summary Table

UnitMeaning
U/L or IU/Lmicromoles per minute per liter
nkat/Lnanokatals per liter
µkat/Lmicrokatals per liter
nmol/(s·L)nanomoles per second per liter
µmol/(s·L)micromoles per second per liter
µmol/(min·L)micromoles per minute per liter
µmol/(h·L)micromoles per hour per liter
µmol/(h·mL)micromoles per hour per milliliter

Diagnostic Uses

1. Rhabdomyolysis

  • CK rises within 2–12 hours after muscle injury
  • Peaks at 24–72 hours
  • Declines over 3–7 days
  • Essential for monitoring severity

2. Neuromuscular Disorders

Elevated CK seen in:

  • Duchenne/Becker muscular dystrophy
  • Polymyositis / dermatomyositis
  • Myotonic dystrophy

3. Myocardial Injury (Historical Use)

CK-MB now preferred for cardiac evaluation.

4. Hypothyroidism

High CK is a classic finding.

5. Drug or Toxin Exposure

Monitor CK in:

  • Statin therapy
  • Alcohol use
  • Illicit drugs (cocaine, amphetamines)

6. Exercise Physiology

CK tracks skeletal muscle stress.

Analytical Notes

  • Serum preferred
  • Hemolysis increases CK slightly
  • Avoid IM injections prior to testing (may raise CK)
  • Macro-CK (bound CK) may falsely elevate values
  • IFCC standardized kinetic rate assays used in modern analyzers

Clinical Pearls

  • CK >10,000 U/L strongly suggests rhabdomyolysis → aggressive IV fluids required.
  • Statin-induced myopathy: CK 10× upper limit + muscle symptoms.
  • CK-MB fraction helps differentiate cardiac vs skeletal source when needed.
  • Hypothyroidism is a treatable cause of chronic CK elevation.
  • CK can remain normal in some muscular dystrophies in late disease due to muscle loss.

Interesting Fact

Creatine kinase is one of the first enzymes released during muscle injury and can increase over 100-fold in severe rhabdomyolysis.

References

  1. Tietz Clinical Chemistry & Molecular Diagnostics, 8th Edition - Enzymes.
  2. IFCC Reference Methods for CK Measurement.
  3. Mayo Clinic Laboratories - CK.
  4. ARUP Consult - Muscle Disease Evaluation.
  5. AAN Neuromuscular Disorder Guidelines.

Last updated: January 26, 2026

Reviewed by : Medical Review Board

Change language

Other Convertors